Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Tandem Diabetes Care, Inc. (NASDAQ: TNDM).

Full DD Report for TNDM

You must become a subscriber to view this report.


Recent News from (NASDAQ: TNDM)

Small Caps Are Rising, Biotechs Can't Be Far Behind
Market Pulse The S&P 500 has finally emerged from its 7-month consolidation as it weaves its way back to chalking all-time highs. While that is an event worth acknowledging, it may not be as breathless a milestone when one realizes that the small cap Russell 2000 index led the market and...
Source: SeekingAlpha
Date: September, 05 2018 13:31
Today's Research Reports on Trending Tickers: Tandem Diabetes Care and DaVita
NEW YORK, NY / ACCESSWIRE / August 31, 2018 / Wall Street retreated from records on Thursday, on news that U.S. President Donald Trump wants to move ahead with his plan to slap tariffs on $200 billion worth additional Chinese imports. Investors will appear to fret if current administration ...
Source: ACCESSWIRE IA
Date: August, 31 2018 08:00
Tandem Diabetes Care to Present at the Baird Global Healthcare Conference
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring integration, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Baird 2018 Global He...
Source: Business Wire
Date: August, 29 2018 16:05
Today's Research Reports on Trending Tickers: Tandem Diabetes Care and Align Technology
NEW YORK, NY / ACCESSWIRE / August 28, 2018 / U.S. markets rose Monday, with the S&P 500 and Nasdaq finishing at new records for the second consecutive session, on news of the new trade agreement with the U.S. and Mexico. The Dow Jones Industrial Average jumped 1.01 percent to close at 2...
Source: ACCESSWIRE IA
Date: August, 28 2018 08:00
When The Market Gets It Wrong - Cramer's Mad Money (8/23/18)
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday , August 23. The earnings season is almost over, and looking back, there was a lot of drama. The market's reaction to some earnings was bizarre. "The market's idiocy? Well, let's just say it's you...
Source: SeekingAlpha
Date: August, 24 2018 07:36
With Overhang Gone, BTCY Could Generate Triple Digit Returns for Shareholders
Ekso Bionics (EKSO) shares traded from$1.80 to $3.00 in the past 30 days based on commercial success and the potential for a substantial bump in revenue soon. Investors recently long EKSO have made 65% with more potential upside to come. Tandem Diabetes Care, Inc. (TNDM) has traded f...
Source: ACCESSWIRE IA
Date: August, 20 2018 07:30
Week 34 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 34: Market conditions continue with low positive breakout momentum and increasing negative momentum. The positive momentum gauge has continued to decline into the red to 19 down from a value of 37 at the end of the prior week. The red positive momentum...
Source: SeekingAlpha
Date: August, 20 2018 06:12
Your Daily Pharma Scoop: Opdivo Is Approved On SCLC, Mateon Trial On Hold, Tandem Product Launch
Stocks in News: BMY, MATN FDA OKs Bristol-Myers' Opdivo for small cell lung cancer Discussion : Bristol-Myers Squibb's ( BMY ) OPDIVO (nivolumab) is now FDA approved for patients with metastatic small cell lung cancer (‘SCLC) that has progressed after platinum-based ch...
Source: SeekingAlpha
Date: August, 19 2018 13:02
Tandem Diabetes launches t:slim X2 insulin pump in U.S.; shares up 1% premarket
Tandem Diabetes Care (NASDAQ: TNDM ) is up  1%  premarket on light volume on the heels of its announcement of the U.S. commercial launch of the t:slim X2 Insulin Pump with Basal-IQ technology, a low glucose suspend feature designed to reduce the frequency and duration of hypoglyc...
Source: SeekingAlpha
Date: August, 17 2018 09:21
Tandem Diabetes Care Announces Commercial Launch of t:slim X2 Insulin Pump with Basal-IQ Technology in the United States
Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps with continuous glucose monitoring (CGM) integration, today announced its launch of the t:slim X2™ Insulin Pump with Basal-IQ™ Technology, a predicti...
Source: Business Wire
Date: August, 17 2018 09:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-0843.6445.1846.6343.112,871,825
2018-05-1711.6711.6911.961811.40901,925
2017-03-101.851.8751.901.8521,443
2017-03-092.101.902.151.85952,483
2017-03-082.352.152.352.10460,618

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0790,378257,27635.1288Short
2018-12-06115,415314,00136.7563Short
2018-12-04230,542457,70150.3696Short
2018-12-03331,818511,40464.8837Short
2018-11-30204,081409,75449.8057Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on TNDM.


About Tandem Diabetes Care, Inc. (NASDAQ: TNDM)

Logo for Tandem Diabetes Care, Inc. (NASDAQ: TNDM)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Market Cap: $44,703,748 - 05/11/2018
    • Issue and Outstanding: 5,022,893 - 10/10/2017

     


    Recent Filings from (NASDAQ: TNDM)

    Amendment to the SC 13G filing
    Filing Type: SC 13G/AFiling Source: edgar
    Filing Date: May, 08 2018
    Additional proxy soliciting materials - definitive
    Filing Type: DEFA14AFiling Source: edgar
    Filing Date: May, 04 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: May, 01 2018
    Additional proxy soliciting materials - definitive
    Filing Type: DEFA14AFiling Source: edgar
    Filing Date: May, 01 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: April, 26 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: April, 26 2018
    Simplified registration form
    Filing Type: S-3Filing Source: edgar
    Filing Date: April, 26 2018
    Official notification to shareholders of matters to be brought to a vote (Proxy)
    Filing Type: DEF 14AFiling Source: edgar
    Filing Date: April, 26 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: April, 10 2018
    Preliminary proxy statement providing notification matters to be brought to a vote
    Filing Type: PRE 14AFiling Source: edgar
    Filing Date: March, 21 2018

     

     


    Daily Technical Chart for (NASDAQ: TNDM)

    Daily Technical Chart for (NASDAQ: TNDM)


    Stay tuned for daily updates and more on (NASDAQ: TNDM)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: TNDM)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in TNDM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of TNDM and does not buy, sell, or trade any shares of TNDM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/